Edition:
United States

Alliance Pharma PLC (ALAPH.L)

ALAPH.L on London Stock Exchange

53.99GBp
6:37am EDT
Change (% chg)

0.49 (+0.91%)
Prev Close
53.50
Open
54.50
Day's High
54.50
Day's Low
53.99
Volume
185,436
Avg. Vol
1,192,505
52-wk High
57.56
52-wk Low
41.33

Latest Key Developments (Source: Significant Developments)

Alliance Pharma says does not see any issues over market access
Tuesday, 19 Jul 2016 02:00am EDT 

Alliance Pharma Plc : Do not anticipate any issues over market access due to uk's decision to leave european union . If current exchange rates prevail sees modest benefit to our sales and financial performance . H1 sales 3.5 million stg . Performed in line with board's expectations with sales more than doubling to £46.4m (2015: £22.8m) for 6 mths to 30 june . Too early to assess long-term impact of uk's decision to leave european union .Do not expect to be adversely affected by current sterling exchange rate volatility.  Full Article

UPDATE 1-Britain's Alliance Pharma H1 revenue rises on strong sales abroad

Sept 13 British specialty pharmaceutical company Alliance Pharma Plc on Wednesday reported an 8.4 percent rise in first-half revenue, helped by international sales of its scar reduction product and eye supplement.

No consensus analysis data available.